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Abstract
Reactive arthritis is the development of sterile joint inflammation as a sequel to a remote infection, often in the gut.
We have previously shown that a low dose of S. enteritidis inoculated to streptomycin-pretreated mice generates a
self-limiting enterocolitis suitable for studying reactive arthritis. Here we show that consumption of Lactobacillus casei
prior to infection abolishes intestinal and joint inflammation triggered by Salmonella. BALB/c mice were sacrificed
after infection; intestinal and joint samples were analyzed for histological changes and expression of cytokines. TNF-
α was measured by ELISA and the expression of IL-1β, IL-6, IL-10, IL-17, IL-23 and TGF-β was assessed by qPCR.
L. casei consumption prevented Salmonella-induced synovitis, the increment of TNF-α in knees and the increase of
IL-17 expression in popliteal and inguinal lymph nodes. At intestinal level consumption of L. casei drastically
diminished S. enteritidis invasiveness and shortened splenic persistence of the pathogen. Bacterial loads recovered
at days 2 and 5 from Peyer’s patches were 10-fold lower in mice fed with L. casei. In accordance, we found that the
augment in gut permeability induced during enterocolitis was decreased in those animals. Consumption of L. casei
prior to infection failed to increase anti- inflammatory molecules such as IL-10 and TGF-β in the intestine. On the
other hand, consumption of L. casei abrogated the expression of TNF-α, IL-17, IL-23, IL-1β and IL-6 in cecum and
mesenteric lymph nodes. These cytokines are needed for differentiation of immune cells involved in the development
of reactive arthritis such as Th17 and γδ T cells. Trafficking of these inflammatory cells from the gut to the joints has
been proposed as a mechanism of generation of reactive arthritis. Our results suggest that L. casei consumption
prevents Salmonella-induced synovitis by altering the intestinal milieu necessary for differentiation of cells involved in
the generation of joint inflammation.
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Introduction
A close association exists between the generation of gut
inflammation and joint disease. An early clue to this link was
the observation that certain bacterial enteropathogens can
induce reactive arthritis (ReA). In this sense, ReA is defined as
the sterile inflammation of joint tissues following a distant
mucosal infection, often gastrointestinal [1]. In developing
countries one-third of all ReA cases are triggered by
Salmonella enterocolitis [2].
Salmonella enterica serotype Typhimurium (S. Typhimurium)
and S. Enteritidis, the two most abundant serotypes for
salmonellosis, elicit an acute inflammatory response in the
intestinal mucosa of humans that can be modeled using
streptomycin-pretreated mice [3]. This inflammatory reaction is
initiated by direct contact of Salmonella with host cells, such as
epithelial cells, macrophages or dendritic cells, followed by an
amplification of inflammatory responses in tissue [4]. As a
result, changes in gene expression are observed in the
intestinal mucosa during Salmonella infection, including
markedly increased mRNA levels of interleukin-17 and IL-23
genes [5]. T cells play an important role in amplifying
inflammatory responses in the cecal mucosa; trafficking of
these gut inflammatory cells towards the joints has been
proposed as a mechanism of generation of ReA [6].
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Probiotics are defined by FAO and WHO as live
microorganisms which when administered in adequate
amounts, confer a health benefit to the host [7]. Orally
administered probiotics exhibit widespread effects on gut
homeostasis and immunomodulation of both mucosal and
systemic immunity. It is well documented that probiotics may
counterweight aggressive enteric pathogens in the gut,
reinforce the barrier function of the epithelium and contribute in
the regulation of innate and adaptive immune responses of the
host under healthy or pathogenic conditions [8]. Lactobacillus
casei DN-114 001 is a probiotic strain that survives intestinal
transit [9] and exerts beneficial effects in vivo. This probiotic
strain is able to modify the digestive microflora and enhance
the immune system during its transit in the digestive tract
[10,11]. It was also shown that Lactobacillus casei DN-114 001
is able to reduce the incidence and duration of diarrhea in
children [12,13]. Moreover, this probiotic interacts with human
intestinal mucosa and can markedly reduce the mucosal
release of inflammatory cytokines in active Crohn’s disease
[14,15]. Nevertheless, the use of probiotics to prevent ReA has
not been investigated, probably because of the lack of an
adequate experimental model. In this regard, investigation on
the pathogenesis of ReA is difficult because of the limited
studies that can be performed in humans; therefore, the
availability of animal models is crucial. We have recently
showed that a low dose of S. Enteritidis inoculated to
streptomycin-pretreated mice generates a self-limiting
enterocolitis model useful for studying ReA [16]. In the present
work, using this animal model of intestinal infection we were
able to determine the protective role of Lactobacillus casei
DN-114 001 fermented milk (LCFM) on the development of
ReA associated to Salmonella enterocolitis.
Materials and Methods
Mice
Six to 8 – week old female BALB/c mice were obtained from
our vivarium, maintained under standard conditions and
provided with food and water ad libitum. At the end of each
experiment, mice were killed with carbon dioxide. All
experimental protocols were approved by the Animal Ethics
Committee, University of Buenos Aires.
Bacteria
Wild-type strain of Salmonella enterica serovar Enteritidis
#5694 (S. Enteritidis) was used to infect mice. Bacteria were
cultured in trypticase soy broth at 37 °C, 200 cycles per minute,
then pelleted by centrifugation and suspended to the
appropriate density in saline solution. In all cases the number
of bacteria was determined by plating appropriate dilutions on
trypticase soy agar plates.
Salmonella infection and generation of enterocolitis
Mice were pretreated with 20 mg of streptomycin (Sigma
Aldrich) given intragastrically [17] and 24 h later they received
3-4 x 103 CFU of S. Enteritidis by the same route. For
intragastric infection, 0.2 ml of the bacterial suspension was
introduced into the stomach with a 21 G blunt needle on a 1.0
ml plastic syringe.
Probiotic administration
Commercially-available fermented milk containing
Lactobacillus casei DN-114001 (LCFM, Danone S.A.) was
used in this study. LCFM was given to mice ad libitum, as
described elsewhere [18] during 7 consecutive days prior to S.
Enteritidis infection. Mice ingested an average dose of 1 x 108
CFU of LCFM per day.
Experimental groups
Throughout this study five different experimental groups
where used, as shown in Table 1. Results obtained from Strep
group were similar to those presented by the Control and L.
casei + Strep group; therefore, they were not described in
Result section unless otherwise stated. Samples were taken at
days 2, 5 and 14 post Salmonella infection.
Bacterial colonization and persistence
At the indicated times post infection mice were sacrificed and
bacterial loads were analyzed. All Peyer´s patches located
along the large intestine (6 to 8) and one third of the spleen
were removed aseptically from each animal and homogenized
in sterile saline solution. Samples were diluted appropriately in
saline and plated on Salmonella- Shigella (SS) agar. Samples
were also cultured for 18 h in selenite broth for enrichment.
Salmonella-like colonies appearing on SS plates were grown
on triple-sugar-iron agar slants and tested for somatic antigen
O9.
Persistence and colonization of bacteria in knee and
popliteal and inguinal lymph nodes were also studied by PCR.
Tissues were homogenized in 1% PBW (Peptone Buffered
Water). After 24 h of enrichment at 37° C, DNA extraction was
performed using the phenol-chloroform technique [19]. A
Table 1. Experimental groups used throughout this study.
Group of mice Probiotic Streptomycin S. Enteritidis
EC - + +
L. casei + EC + + +
Control - - -
L. casei + Strep + + -
Strep - + -
doi: 10.1371/journal.pone.0082588.t001
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standard PCR of 45 cycles was carried out using selective
primers to amplify invA and sopA genes, of 285 pb and 113 pb
products respectively. Primers used were: forward 5´-
CTGAAATTATCGCCACGTTCGGGCAA – and reverse 5´-
CATCGCACCGTCAAAGGAACC -3´ to amplify invA gene [19]
and forward 5´-TCCACCGTGAAGTTGATTG -3´ and reverse 3
´-GCACTGAGGATGTGCTGGTA –5´ [20] for sopA gene. The
cycling programme was 95° C for 10 s, 55 ° C for 10 s and 72°
C for 15 s and one cycle of 40° C for 30 s. Twenty µl aliquots of
the reaction mixtures were electrophoresed through 2.0%
agarose gel and fragments were revealed by staining with
ethidium bromide.
Histological analysis
Intestinal samples were fixed in formalin and processed by
standard procedures for paraffin embedding. Knee joints were
dissected, fixed in formalin for 2 days, decalcified in EDTA for
30 to 40 days, and then embedded in paraffin. Standard
sections of 5 µm were prepared and stained with haematoxylin-
eosin (HE) using routine histology techniques. An experienced
pathologist blinded to the experimental protocol evaluated
findings of intestine and joint abnormalities. Synovial alterations
were scored as 0 = no changes; 1 = slight thickening of
synovial cell layer (up to 3 layers of synoviocytes)
accompanied by congestion and oedema of the external
membrane; 2 = moderate thickening of synovial cell layer (3 to
5 layers of synoviocytes) accompanied by congestion and
oedema of the external membrane; 3 = severe thickening of
synovial lining (more than 5 layers) accompanied by
congestion and oedema of the external membrane. Intestinal
alterations were scored as 0 = no changes; 1 = oedema and/or
villous capillary dilatation with epithelial preservation; 2 = focal
mucosa irritation characterized by villous hydrops and capillary
dilatation with mild to moderate mononuclear cell infiltration; 3
= similar to 2 but of extended distribution; 4 = mucosal
alteration with mononuclear cell infiltration and loss of epithelial
integrity.
Quantitative real-time reverse transcriptase-polymerase
chain reaction
Total RNA was extracted from tissues using Trizol reagent
(Life Technologies, Inc, Carlsbad, CA) at different time points
according to the experiment. Total RNA (1 µg per sample) was
reverse transcribed with oligo(dT) as primer using Expand
Reverse Transcriptase (Promega Corporation, Madison, WI)
according to the manufacturer’s protocol. Quantitative real-time
reverse transcriptase-polymerase chain reaction was
performed using SyBr Green PCR kit (Applied Biosystems Inc,
Foster City, CA) in an Applied Biosystems 7500 sequence
detector. Primer sequences are described in Table 2. All
samples were analyzed in the same run for 18s expression for
normalization. Polymerase chain reaction parameters were 50°
C for 2 min, 94° C for 2 min, and 40 cycles of 94° C for 30 s
and 60° C. Quantification of gene expression was calculated
using the comparative threshold cycle (Ct) method, normalized
to the 18s control and efficiency of the RT reaction (relative
quantity, 2-∆∆Ct). The replicates were then averaged, and fold
induction was determined, considering the value in “Control”
group as 1 [21].
Cytokine Analysis
For TNF-α determination, knee samples were obtained 5
days after oral inoculation with 3-4 x103 CFU of S. Enteritidis
from mice of EC and L. casei + EC groups. Tissue
Table 2. Oligonucleotides primers used for quantitative real-time reverse transcriptase-PCR assays.
mRNA Targeted Sequence (5’→3’) a Accession numbre PCR product size (nt) Ref.
TNF-α ATGAGCACAGAAAGCATGATC (F) U68415 276 [21]
 TACAGGCTTGTCACTCGAATT (R)    
IL-17 GCTCCAGAAGGCCCTCAGA (F) U43088 142 [5]
 AGCTTTCCCTCCGCATTGA (R)    
IL-1β TTGACAGTGATGAGAATGACC (F) NM_008361 252 [21]
 CAAAGATGAAGGAAAAGAAGG (R)    
IL-6 TGATGCACTTGCAGAAAACAA (F) NM_031168 328 [21]
 GGTCTTGGTCCTTAGCCACTC (R)    
IL-23 TGTGCCTAGGAGTAGCAGTCCTGA (F) NM_031252 226 [5]
 TTGGCGGATCCTTTGCAAGCAGAA (R)    
IL-10 CCAAGCCTTATCGGAAATGA (F) NM_010548 162 [21]
 TTTTCACAGGGGAGAAATCG (R)    
TGF-β ACCAACTACTGCTTCAGCTC (F) NM_011577 194 [22]
 TGTTGGTTGTAGAGGGCAAG (R)    
18s rRNA AACACGGGAAACCTCACCC(F) GU372691 103 [21]
 CCACCAACTAAGAACGGCCA (R)    
Primers were purchased from Invitrogen Inc. and were designed according to the DNA sequence information available for Mus musculus (M. musculus blast server BLAST
Server Database at www.sanger.ac.uk).
a F, forward primer; R, reverse primer.
doi: 10.1371/journal.pone.0082588.t002
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homogenates from 5 animals were pooled and subjected to
centrifugation (12.000 rpm, 1 min) to pellet all cell debris prior
to concentration using an Amicon Ultra-4 Centrifugal Filter Unit
(Merck Millipore). Supernatants were stored at -20°C until
further use. Analyses were conducted using commercially
available enzyme-linked immunosorbent assay (ELISA) kits
(R&D Systems, Minneapolis, MN) according to manufacturer's
instructions. Cytokine levels were expressed as picogram per
ml (pg/ml).
Intestinal permeability in vivo
The intestinal permeability was measured by determining the
amount of FITC- dextran in blood after it was orally
administered as described previously [23]. Briefly, each mouse
received 440 mg/kg of body weight of FITC- dextran (molecular
weight 4.4 kDa; Sigma-Aldrich) by gavage. A blood sample,
obtained 5 h later, was first centrifuged (3.000 rpm at 4° C) for
30 min, serum was collected and added to a 96- well
microplate. The concentration of FITC- dextran was determined
by spectrophotofluorometry with an excitation wavelength of
483 nm and an emission wavelength of 525 nm using serially
diluted samples of the marker as standard.
Statistical analysis
Statistically significant differences between experimental
groups were determined by one-way analysis of variance
(ANOVA) followed by Tukey test for multiple comparisons.
Statistical analysis was performed using the software program
Prism 4.0 (GraphPad Software, San Diego, CA, USA). P-
values less than 0.05 were considered statistically significant.
Results
Consumption of LCFM prevents joint inflammation
associated with Salmonella enterocolitis
Experiments were conducted using a model in which
streptomycin-pretreated mice are infected with a low dose of S.
Enteritidis in order to induce enterocolitis [16]. Mice received 20
mg of streptomycin 24 h before intragastric infection with 3 to 4
x 103 CFU of the pathogen (EC group). The experimental group
was fed with LCFM for one week prior to the induction of
Salmonella enterocolitis (L. casei + EC group). Mice treated
with streptomycin only (Strep group), fed with L. casei and
streptomycin (L. casei + Strep) and animals without any
treatment (Control group) were included as controls. As shown
earlier [16], 5 days after the induction of Salmonella
enterocolitis, animals of the EC group presented synovitis with
moderate hyperplasia of the synovial membrane and
mononuclear infiltration (Figure 1A); lesions observed
corresponded to a pathological score of 2 (Figure 1D).
Interestingly, mice fed with the LCFM one week prior to the
onset of enterocolitis (L.casei + EC) did not present any joint
alteration (Figure 1B); their synovial membranes were healthy
and similar to those from the Control group (Figure 1C) with a
pathological score of 0 (Figure 1D). Results obtained from L.
casei + Strep group were similar to those presented by the
Control group (data not shown).
Because local production of TNF-α appears to be
responsible for synovial inflammation induced during S.
Enteritidis intestinal infection [16], we analyzed whether
consumption of the probiotic modifies the production of this
inflammatory molecule. The amount of TNF-α was determined
by ELISA in joint homogenates 5 days after the onset of S.
Enteritidis enterocolitis. As shown in Figure 2A, the increase of
articular TNF-α observed in animals suffering enterocolitis (EC
group) was abrogated by the consumption of LCFM prior to S.
Enteritidis infection (L. casei + EC group). The amount of TNF-
α in L. casei + Strep group was similar to that from untreated
animals. These results would indicate that the prevention of
synovitis observed in L. casei + EC group is closely related to
the absence of local TNF-α.
It has been shown that TNF-α production and synovitis are
related to the expression of IL-17 in joint draining lymph nodes
[16,24]. With this in mind we analyzed the expression of IL-17
mRNA in popliteal and inguinal lymph nodes during Salmonella
enterocolitis in animals with or without probiotic treatment.
Figure 2B shows that the increase in IL-17 expression induced
by Salmonella enterocolitis in lymph nodes draining the
inflamed joints (EC group) was significantly lower (p<0.01) in
animals fed with LCFM (L. casei + EC group). Expression of
IL-17 mRNA was similar in L. casei + EC, Control and L. casei
+ Strep groups.
Consumption of LCFM prevents Salmonella- induced
enterocolitis
To this point our results show that ingestion of LCFM can
prevent synovitis triggered by S. Enteritidis enterocolitis. The
prominent link between intestinal and joint inflammation has
been known for many years [25]. Therefore, it is likely that the
beneficial effect of the probiotic on inflamed joints is related to
the preservation of intestinal health during Salmonella
enterocolitis. We next analyzed the effect of LCFM
consumption on the intestinal inflammatory response to S.
Enteritidis. Mice treated with streptomycin only (Strep group),
fed with L. casei and streptomycin (L. casei + Strep) and
animals without any treatment (Control group) were included as
controls. Forty-eight hours after infection animals of the EC
group presented signs of disease including diarrhea, rough hair
coat, and lethargy. We found that S. Enteritidis induces diffuse
enterocolitis, characterized by an epithelium diminished in
height, mononuclear infiltration of the mucosa and submucosa,
and loss of normal villus architecture (Figure 3A).
Administration of LCFM for one week prior to infection
prevented histological changes (L. casei + EC group; Figure
3B) as well as the clinical symptoms. The average histological
score observed during Salmonella enterocolitis diminished from
3 in EC group to 0 in mice fed with the probiotic (L. casei + EC
group); the latter was similar to Control group (Figure 3C and
D). In addition, results obtained from L. casei + Strep group
were similar to those presented by the Control group (data not
shown).
The protective effect of LCFM observed on intestinal
epithelium and clinical features could be related to the
significant decrease in the bacterial invasion observed in the L.
casei + EC group. It has been demonstrated that serovar
L. casei Consumption Prevents Salmonella ReA
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Enteritidis has high blood invasiveness generating extra-
intestinal focus of infection with elevated rates of mortality [26].
Our results clearly indicate that consumption of LCFM
drastically diminishes S. Enteritidis invasiveness and shortens
splenic persistence of the pathogen. Colonization and
persistence of S. Enteritidis were analyzed at days 2, 5, and 14
Figure 1.  Effect of LCFM consumption on joint pathology during Salmonella enterocolitis.  A to C: Histology of knee joints 5
days after oral inoculation with the pathogen. D: Synovial inflammation scores. EC group: mice received 20 mg of streptomycin 24 h
before intragastric infection with 3-4 x 103 CFU of S. Enteritidis. L. casei + EC group: mice received the probiotic for a week before
enterocolitis onset. Control group: untreated mice. (A) EC group: moderate hyperplasia, with 3 to 5 layers of synoviocytes (arrows).
(B) L. casei + EC group: normal synovial capsule (arrows), undistinguishable from Control group. (C) Control animals: normal
synovial capsule (arrows). HE; 40x. Data were collected from 3 independent experiments.
doi: 10.1371/journal.pone.0082588.g001
Figure 2.  Effect of LCFM consumption on joint during Salmonella enterocolitis.  A. TNF-α was measured in joint
homogenates by ELISA 5 days after oral infection with the pathogen. Five animals per group were analyzed. B. IL-17 expression
was analyzed by qPCR at day 5 post infection in joint draining lymph nodes. Seven animals per group were analyzed. EC group:
mice received 20 mg of streptomycin 24 h before intragastric infection with 3-4 x 103 CFU of S. Enteritidis. L. casei + EC group: mice
received the probiotic for a week before enterocolitis onset. Control group: untreated mice. L. casei + Strep group: animals were fed
with the probiotic for a week and then received streptomycin. Results are expressed as mean +/- SD. (NS): no significant
differences. Data were collected from 3 independent experiments.
doi: 10.1371/journal.pone.0082588.g002
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postinfection (Table 3). Bacterial loads recovered at days 2 and
5 from Peyer’s patches were 10-fold lower in L. casei + EC
group than in EC group. The effect of consumption of LCFM on
spleen was even more dramatic. The intake of probiotics prior
to Salmonella infection not only significantly decreased
bacterial load, but also shortened infection period. Salmonella
was still colonizing spleen at day 14 in EC group, whereas by
that time this organ was sterile in animals from L. casei + EC
group (Table 3). It is worth mentioning that in L. casei + EC
group bacterial cultures were positive only after enrichment.
Preserved intestinal epithelium and diminished bacterial
invasiveness induced by LCFM correlated with 100% survival
rate of animals from L. casei + EC group. Approximately 20%
of mice with Salmonella enterocolitis die by day 7 post infection
[16]; as shown in Table 3 no deaths occurred among mice fed
with LCFM prior to infection. Neither live Salmonella nor their
DNA were detected in joints or draining lymph nodes at any
time tested for any group analyzed (data not shown).
It has been shown that intestinal permeability increases
during enterocolitis [27]. We next decided to investigate the
effect of LCFM on gut permeability during Salmonella
enterocolitis. For that purpose, we administered a single dose
of FITC–dextran by gavage to the animals at day 2 post
infection and measured the intensity of fluorescence in serum 5
h later. As shown in Figure 4, the augment in gut permeability
to macromolecules induced by Salmonella enterocolitis (EC
group) was decreased by the consumption of LCFM to the
same extent as found in healthy mice (L. casei + EC, L. casei +
Strep and Control groups). It is likely then, that the
enhancement of gut barrier function induced by LCFM
consumption will prevent the intestinal response to the
pathogen and consequently the associated joint sequelae.
Consumption of LCFM prevents the expression of local
inflammatory molecules induced by Salmonella
enterocolitis
Next we intended to analyze through which mechanism
LCFM intake abrogates the inflammatory reaction of the gut
against S. Enteritidis. Therapeutic efficacy of L. casei
consumption is usually associated with the induction of anti-
inflammatory molecules such as IL-10, TGF-β [28,29]. To test
whether IL-10 and TGF-β are induced after LCFM
consumption, we investigated the intestinal expression of these
cytokines in mice treated with L. casei only. As shown in Figure
5 no increase in either cytokine expression was found in any
Figure 3.  Effect of LCFM consumption on intestinal pathology during Salmonella enterocolitis.  A to C: Histology of the
intestine 2 days after oral infection with the pathogen. D: Intestinal inflammation scores. EC group: mice received 20 mg of
streptomycin 24 h before intragastric infection with 3-4 x 103 CFU of S. Enteritidis. L. casei + EC group: mice received the probiotic
for a week before enterocolitis onset. Control group: untreated mice. (A) EC group: moderate enterocolitis, loss of normal villus
architecture and height. (B) L. casei + EC group: regular display of intestinal villus, undistinguishable from Control group (C). HE;
40x. (NS): no significant differences. Data were collected from 3 independent experiments.
doi: 10.1371/journal.pone.0082588.g003
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experimental group studied. These results suggest that the
mechanism through which LCFM prevents intestinal response
to S. Enteritidis is not the elevation of the anti inflammatory
cytokines.
We then wondered whether probiotic treatment affects the
expression of inflammatory cytokines triggered by Salmonella
enterocolitis. Soon after intestinal infection S. enterica induces
a significant increase in the expression of IL-17 and related
cytokines such as TNF-α, IL-1β, IL-6 and IL-23 [5,16].
Interestingly, a substantial amount of data also links arthritis
development to the expression of IL-17 and related cytokines
[30]. As shown in Figure 6, during enterocolitis intestinal TNF-α
is 7 times higher than in animals without S. Enteritidis infection
(Control and L. casei + Strep groups); similarly, IL-17 and IL-23
are significantly elevated (11 and 5 times higher compared to
controls, respectively). Interestingly, animals fed with the
probiotic (L. casei + EC) did not respond to the pathogen
burden, since the expression of IL-17 and related cytokines
was similar to that seen in uninfected mice (Figure 6). No
changes in the expression of intestinal IL-1β and IL-6 were
observed at day 2 post infection (Figure 6).
The anti inflammatory effect of LCFM was even more
dramatic in mesenteric lymph nodes. As shown in Figure 7,
animals suffering from Salmonella enterocolitis (EC group)
showed more than 30 fold increase in IL-17, 3-fold increase in
IL-23, 50-fold increase in IL-1β and 3-fold increase in IL-6,
compared to Control and L. casei + Strep groups. Consumption
of LCFM (L. casei + EC group) abrogated the expression of all
Table 3. Effect of LCMF on colonization, persistence and survival during Salmonella enterocolitis.
Treatment Dose CFU/mice Days p.i. Peyer´s Patches (CFU/ml)(a) Spleen (CFU/ml)(a) Survival rate(b)
EC 3-4 x 103 2 52 (19-78) 65 (23-89) 5/5
  5 66 (24-113) 88 (32-111) 4/5
  14 Negative 55 (17-63) 4/5
L. casei + EC 3-4 x 103 2 <5* <5 5/5
  5 <5 <5 5/5
  14 Negative Negative 5/5
Mice received 20 mg of streptomycin 24 h before intragastric infection with 3-4 x 103 CFU of Salmonella enterica (EC group). L. casei + EC group received probiotic for a
week before EC onset. At day 2, 5 and 14 after infection mice were sacrificed.
(a) Median (range). * S. Enteritidis was isolated only after enrichment in selenite broth. Survival rate: Number of survivors/total number of mice.
(b) Number of survivors/total number of mice.
doi: 10.1371/journal.pone.0082588.t003
Figure 4.  Effect of LCFM on intestinal permeability after Salmonella enterocolitis.  A single dose of FITC–dextran was
administered by gavage to the animals at day 2 post infection and the intensity of fluorescence was measured in serum 5 h later.
EC group: mice received 20 mg of streptomycin 24 h before intragastric infection with 3-4 x 103 CFU of S. Enteritidis. L. casei + EC
group: mice received the probiotic for a week before enterocolitis onset. Control group: uninfected mice. L. casei + Strep group:
animals were fed with the probiotic for a week and then received streptomycin. Results are expressed as mean +/- SD. Seven
animals per group were analyzed. (NS): no significant differences. Representative data from 3 independent experiments.
doi: 10.1371/journal.pone.0082588.g004
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cytokines induced by Salmonella enterocolitis in mesenteric
lymph nodes at day 5 post infection (Figure 7).
Discussion
ReA is the development of sterile inflammatory arthritis as a
sequel to a remote infection, often in the gastrointestinal tract.
As stated before, in developing countries, more than thirty
percent of ReA cases are associated with Salmonella
enterocolitis [2]. Earlier we showed that oral infection with a low
dose of S. Enteritidis induced to streptomycin-pretreated mice
renders a suitable model for studying the pathogenesis of
Salmonella ReA [16]. Here we demonstrate that consumption
Figure 5.  Effect of LCFM on intestinal IL-10 and TGF-β.  Cytokines expression was analyzed by qPCR. L. casei only group: mice
fed for a week with LCFM. EC group: mice received 20 mg of streptomycin 24 h before intragastric infection with 3-4 x 103 CFU of S.
Enteritidis. L. casei + EC group: mice received the probiotic for a week before enterocolitis onset. Control group: untreated mice. L.
casei + Strep group: animals were fed with the probiotic for a week and then received streptomycin. Results are expressed as mean
+/- SD. Four animals per group were analyzed. (NS): no significant differences. Representative data from 3 independent
experiments.
doi: 10.1371/journal.pone.0082588.g005
Figure 6.  Effect of LCFM on intestinal cytokines after Salmonella enterocolitis.  Cytokine expression was analyzed by qPCR 2
days after oral inoculation with 3-4 x 103 UFC of the pathogen. EC group: mice received 20 mg of streptomycin 24 h before
intragastric infection with 3-4 x 103 CFU of S. Enteritidis. L. casei + EC group: mice received the probiotic for a week before
enterocolitis onset. Control group: untreated mice. L. casei + Strep group: animals were fed with the probiotic for a week and then
received streptomycin. Results are expressed as mean +/- SD. Seven animals per group were analyzed. (NS): no significant
differences. Representative data from 3 independent experiments.
doi: 10.1371/journal.pone.0082588.g006
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of LCFM prior to infection abolishes intestinal and joint
inflammation triggered by Salmonella enterocolitis.
Three main mechanisms of how probiotics can protect from
intestinal inflammation have been described. First, probiotics
may exclude or inhibit the growth of certain pathogens [31];
second, they may improve the gut barrier function [32]; and
third, they can modulate mucosal and/or systemic immune
response or metabolic functions [33]. The outcome of probiotic
therapy also depends on the stage of the disease and the
overall health status of the patient.
We found that, at intestinal level, LCFM significantly reduced
colonization and invasion of S. Enteritidis. Similar results have
been recently reported by Castillo et al [34]; they found that
continuous administration of L. casei to Salmonella-infected
mice reduces significantly the pathogen counts in spleen, liver
and large intestine. Adhesion of probiotic bacteria to the
gastrointestinal surface is considered critical for the competitive
exclusion of pathogens and for modulation of local and
systemic immunological activities [35,36]. Specific adhesin-
receptor interactions are one of the major mechanisms for the
adhesion of bacteria to gastrointestinal surfaces. Thus,
competition for adhesion between probiotics and intestinal
pathogens could explain the beneficial effect of LCFM
consumption on animals suffering from Salmonella
enterocolitis. In support to this hypothesis, it has been shown
that probiotics like L. casei Shirota present surface adhesins
which are closely related to those found in Salmonella
Typhimurium and Enteritidis [37]. In addition, it is likely that
products secreted by L. casei and present in the fermented
milk could interfere with Salmonella adhesion to intestinal
epithelium. Fucose for instance, which is secreted by L. casei
upon fermentation of N-acetylglucosamine, could certainly
block Salmonella Std fimbriae. These adhesins, required for
Salmonella enterica attachment and cecal colonization,
recognize fucose residues on the epithelial cells [38–40].
We also found that Salmonella invasion is significantly
diminished in LCFM-fed mice. This finding is in agreement with
previous studies showing that probiotic consumption can
strengthen the gut barrier function [41,42]. In mice suffering
from dextran sulfate sodium-induced colitis L. casei leads to a
significant protection against increased intestinal permeability
[43]. Likewise, in our experiments, intake of LCFM prevented
the increased permeability induced by Salmonella enterocolitis.
Certain enteric pathogens regulate epithelial permeability by
modifying expression and localization of tight junction proteins.
Salmonella spp., for instance, disrupt tight junction proteins by
means of effector proteins secreted through the type three
secretion system (TTSS) [44,45]. Intimate attachment between
bacteria and eukaryotic cells is an indispensable prerequisite
condition to translocate effector proteins through TTSS-1 [46].
Therefore, prevention of Salmonella adhesion to the
intestinal epithelium by LCFM could abrogate not only bacterial
colonization but also translocation of effector proteins involved
in disruption of intestinal barrier and bacterial invasion.
Moreover, avoiding traslocation of effector proteins such as
SopB, SopE and SopE2, could also explain the attenuation of
the intestinal inflammatory response to Salmonella observed in
LCFM fed mice. Different probiotic bacteria, including L. casei,
can exert their anti inflammatory effect increasing the
production of IL-10 and TGF-β by T cells [28,29]. In our model,
however, neither intestinal IL-10 nor TGF-β expression was
induced by LCFM. Our results are in line with a recent study in
mice showing that Bifidobacterium breve -but not L. casei- is
able to induce IL-10-producing T cells in the colon [47].
Furthermore, Chung et al showed that colonic TGF-β
expression does not augment in L. casei treated animals [48]. It
Figure 7.  Effect of LCFM on mesenteric cytokines after Salmonella enterocolitis.  Cytokine expression was analyzed by qPCR
5 days after oral inoculation with 3-4 x 103 UFC of the pathogen. EC group: mice received 20 mg of streptomycin 24 h before
intragastric infection with 3-4 x 103 CFU of S. Enteritidis. L. casei + EC group: mice received the probiotic for a week before
enterocolitis onset. Control group: untreated mice. L. casei + Strep group: animals were fed with the probiotic for a week and then
received streptomycin. Results are expressed as mean +/- SD. Seven animals per group were analyzed. (NS): no significant
differences. Representative data from 3 independent experiments.
doi: 10.1371/journal.pone.0082588.g007
L. casei Consumption Prevents Salmonella ReA
PLOS ONE | www.plosone.org 9 December 2013 | Volume 8 | Issue 12 | e82588
is likely then, that the anti inflammatory effect observed in the
gut (and joints) of mice pre treated with the LCFM is related not
to the induction of anti inflammatory cytokines but rather to the
prevention of the expression of inflammatory molecules.
In previous studies we showed that intestinal IL-17 induced
by Salmonella enterocolitis is directly related to the induction of
joint inflammation and that neutralization of IL-17 in Salmonella
infected animals resulted in the abrogation of synovitis [16].
Furthermore, intestinal infection with ΔinvG mutant of
Salmonella, bearing a defective TTSS-1, triggers neither
intestinal inflammatory IL-17 nor joint inflammation [16,49]. In
the present work we show that consumption of LCFM prevents
IL-17 intestinal response to Salmonella and at the same time
blocks the induction of joint inflammation.
Upon Salmonella infection, the IL-23/IL-17 axis is triggered in
the intestinal mucosa. Macrophages and dendritic cells infected
with Salmonella are a potential source of IL-23, a cytokine that
helps to amplify the inflammatory response in intestinal tissue.
Thus, IL-23 produced by phagocytes stimulates, in turn, T cells
to secrete IL-17 [5]. Different T cells -like Th17, γδ and NKT-
present in the intestinal mucosa and lamina propria express the
receptor for IL-23 and constitute an important source of IL-17
during Salmonella infection [5,50]. Th17, γδ and NKT cells
have been also implicated as a source of IL-17 production in
different animal models of inflammation [51–56] and have been
proposed as the link between gut inflammation and joint
pathology in spondyloarthritis [57]. Trafficking of intestinal
lymphocytes to the joints has been proposed as a theory to
explain the concurrence of gut and joint inflammation [6,25,58].
On the other hand, differentiation of Th17 and γδ T cells
requires a specific cytokine environment that includes IL-1β,
IL-6 IL-23 and TGF-β [59–61]. Here, we show that the
expression of these cytokines are induced during Salmonella
enterocolitis and are abrogated by consumption of LCFM. In
our model, the expression of intestinal inflammatory molecules
concurs with the generation of joint lesions; in contrast, the
abrogation of the expression of intestinal IL-17 and related
cytokines prevents synovitis. This strongly suggests that the
immunomodulatory effect of LCFM may have been achieved
first in the gut and was subsequently expressed in a distant
immune site. Our findings are in agreement with those reported
by Inoue et al using a murine model of atopic dermatitis. They
found that oral administration of Lactobacillus spp. diminished
the expression of CD86 and IL-23 in Peyer´s patches and
mesenteric lymph nodes as well as in skin lesions [62]. Our
results suggest that LCFM consumption alters the intestinal
milieu necessary for differentiation of the immune cells involved
in the generation of joint inflammation.
It is likely that down regulation of intestinal IL-23 by LCFM
itself generates a protective effect on the joint. Numerous
studies have suggested that overproduction of IL-23 is
associated to joint pathologies [63–65] and the intestine
appears as a key site of IL-23 production. As an example, it
was found that in ankylosing spondylitis patients IL-23
expression is upregulated in the ileum. An explanation for this
association has been recently achieved. Entheses contain
resident lymphocytes expressing IL-23 receptor; IL-23 induces
the expression of IL-17 and IL-22 in these T cells, hence
triggering local joint inflammation [66]. Therefore, prevention of
intestinal IL-23 expression during Salmonella enterocolitis
could explain the abrogation of synovitis found in mice fed with
LCFM.
Altogether our results show that consumption of LCFM prior
to Salmonella enterocolitis onset abrogates intestinal
inflammatory response to the pathogen. Expression of
inflammatory cytokines was avoided in gut and joint tissues.
Hence, prevention of the expression of these cytokines in mice
fed with the probiotic could impair the differentiation of immune
cells involved in the development of reactive arthritis.
Furthermore, the abrogation of IL-23 expression in the intestine
of mice receiving LCFM could account for the prevention of
synovitis.
Regarding the pathogenesis of ReA, the role and mechanism
of action of IL-23 are still not fully understood. However, it
seems that IL-23/IL-17 is an important axis in ReA; thus
interfering with the IL-23/IL-17 pathway could be a potential
therapeutic target in the treatment of this disease. A deeper
understanding of the functions and actions of IL-23 as well as
the immune cells that generate it, may be useful in the
management of new methods in the treatment of ReA,
including the use of probiotics after the onset of arthritis.
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